Trial Information

Summary: Inhaled Insulin

An investigational treatment for Type 1 Diabetes.

Inhaled Insulin treatments may improve the quality of life for many patients with diabetes.

Diablo Clinical Research and Diabetes Specialist, Dr. Richard Weinstein, are seeking volunteers with Type 1 Diabetes to help evaluate an investigational Inhaled Insulin.

You may qualify for this clinical research study if you are:

• diagnosed with Type 1 Diabetes
• a non-smoker (for at least 6 months prior)

Qualified participants receive at no cost:

• study medications
• study-related medical care including
  • physician evaluations
  • dietary counseling
• glucose meter and test strips

Qualified participants also receive compensation for time and travel.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: September 9, 2008 at 3:33:04 PM